Surgery Partners Inc (SGRY) Stock Sees Market Value Hit $3.28 billion: What Are the Implications?
BofA Securities has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on October 14, 2024, UBS had initiated the stock to Buy, setting a price target of $38. KeyBanc Capital Markets also initiated Sector Weight rating. Additionally, Macquarie initiated Outperform rating on June […]
Why Is Surgery Partners Inc (SGRY) Stock Surpassing 18.81% from Its 50-Day SMA?
BofA Securities has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on October 14, 2024, UBS had initiated the stock to Buy, setting a price target of $38. KeyBanc Capital Markets also initiated Sector Weight rating. Additionally, Macquarie initiated Outperform rating on June […]
Surgery Partners Inc (SGRY) Stock Settles at $21.25: What’s Contributing to This Price Point?
BofA Securities has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on October 14, 2024, UBS had initiated the stock to Buy, setting a price target of $38. KeyBanc Capital Markets also initiated Sector Weight rating. Additionally, Macquarie initiated Outperform rating on June […]
BofA Securities Issues Buy Rating for Surgery Partners Inc (SGRY) Stock
BofA Securities has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on October 14, 2024, UBS had initiated the stock to Buy, setting a price target of $38. KeyBanc Capital Markets also initiated Sector Weight rating. Additionally, Macquarie initiated Outperform rating on June […]
Why Did Surgery Partners Inc (SGRY) Stock See -36.10% Plunge in the Last 90 Days?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
What Factors Have Led to Surgery Partners Inc (SGRY) Stock Trading -38.99% Below Its 52-Week High?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
Surgery Partners Inc (SGRY) Posted -2.03% Profit Margin Last Year—Can It Hold Up?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
Surgery Partners Inc (SGRY) Stock Settles at $23.41: What’s Contributing to This Price Point?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
Surgery Partners Inc (SGRY) Stock: More Robust Than the Numbers Suggest?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
The Surgery Partners Inc Rollercoaster: What’s Behind the Latest SGRY Stock Fluctuation?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
